Kazakhstan’s Technology Commercialization Project fast approaches its completion in December 2015, and in a relatively short time, has demonstrated outstanding results: its success rate has reached 30%, well above global standards – an achievement that can be viewed through the lens of excellent collaboration between the Kazakh authorities, the World Bank, and international partners.
This World Bank-financed project was designed to improve science in Kazakhstan, using robust tools for the adequate financing of high-quality Kazakhstani research and development (R&D).
The Senior Scientist/Junior Researcher Grant Program financed 33 groups overall to conduct international research and development. Selection and supervision were undertaken by high-level professionals at ISCB. Central to the program was rigorous merit-based selection and performance monitoring in order to ensure achievements in technology commercialization, which was coupled with sufficient funding for a 3 year-period.
One of the program grantees, Elena Zholdybayeva, is a scientist working on human DNA test systems development and says this about the program: “For us as the scientists with no business experience, even the definition of technology commercialization, or business development, was something completely new. However, with the support of the project management unit, the Technology Commercialization Office, and CRDF Global, we have finished our scientific research, created an industrial prototype and have made a great step towards its commercialization: we signed our first commercial contract with the National Research Cardiac Surgery Center in 2013.”